Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
83.59
+0.27 (0.32%)
Nov 20, 2024, 4:00 PM EST - Market closed
Globus Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 2,479 | 1,568 | 1,023 | 958.1 | 789.04 | 785.37 | Upgrade
|
| Revenue Growth (YoY) | 102.10% | 53.34% | 6.76% | 21.43% | 0.47% | 10.15% | Upgrade
|
| Cost of Revenue | 816.66 | 476.52 | 263.73 | 239.22 | 217.46 | 179.98 | Upgrade
|
| Gross Profit | 1,662 | 1,092 | 759.12 | 718.88 | 571.58 | 605.39 | Upgrade
|
| Selling, General & Admin | 968.8 | 643.41 | 432.12 | 408.15 | 354.76 | 354.76 | Upgrade
|
| Research & Development | 180.51 | 124.01 | 73.02 | 97.35 | 84.52 | 60.07 | Upgrade
|
| Operating Expenses | 1,267 | 818.45 | 522.87 | 524.02 | 456.11 | 428.64 | Upgrade
|
| Operating Income | 395.04 | 273.51 | 236.25 | 194.86 | 115.47 | 176.75 | Upgrade
|
| Interest & Investment Income | - | 20.13 | 14.23 | 9.3 | 13.95 | 17.41 | Upgrade
|
| Currency Exchange Gain (Loss) | 14.11 | 14.26 | -1.02 | -1.42 | -0.28 | 0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.38 | -1.35 | 7.24 | 3.36 | 1.38 | -0.61 | Upgrade
|
| EBT Excluding Unusual Items | 400.2 | 306.55 | 256.71 | 206.09 | 130.53 | 193.62 | Upgrade
|
| Merger & Restructuring Charges | -278.32 | -139.93 | -5.96 | -16.98 | -4.03 | -2.58 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.06 | -0.79 | -5.39 | -2.78 | -0.59 | 1.09 | Upgrade
|
| Legal Settlements | -0.88 | -0.43 | -2.34 | -5.92 | -0.01 | -2.19 | Upgrade
|
| Pretax Income | 121.05 | 165.39 | 243.02 | 180.41 | 125.9 | 189.95 | Upgrade
|
| Income Tax Expense | 29.54 | 42.52 | 52.85 | 31.22 | 23.61 | 34.74 | Upgrade
|
| Net Income | 91.51 | 122.87 | 190.17 | 149.19 | 102.29 | 155.21 | Upgrade
|
| Net Income to Common | 91.51 | 122.87 | 190.17 | 149.19 | 102.29 | 155.21 | Upgrade
|
| Net Income Growth | -42.05% | -35.39% | 27.47% | 45.86% | -34.10% | -0.81% | Upgrade
|
| Shares Outstanding (Basic) | 136 | 113 | 100 | 101 | 99 | 99 | Upgrade
|
| Shares Outstanding (Diluted) | 136 | 115 | 103 | 104 | 101 | 102 | Upgrade
|
| Shares Change (YoY) | 25.87% | 11.68% | -0.95% | 2.63% | -1.01% | 0.67% | Upgrade
|
| EPS (Basic) | 0.67 | 1.09 | 1.89 | 1.48 | 1.04 | 1.57 | Upgrade
|
| EPS (Diluted) | 0.67 | 1.07 | 1.85 | 1.44 | 1.01 | 1.52 | Upgrade
|
| EPS Growth | -54.17% | -42.16% | 28.47% | 42.57% | -33.55% | -1.30% | Upgrade
|
| Free Cash Flow | 293.77 | 165.23 | 104.42 | 219.38 | 135.14 | 101.23 | Upgrade
|
| Free Cash Flow Per Share | 2.16 | 1.44 | 1.02 | 2.12 | 1.34 | 0.99 | Upgrade
|
| Gross Margin | 67.05% | 69.62% | 74.22% | 75.03% | 72.44% | 77.08% | Upgrade
|
| Operating Margin | 15.94% | 17.44% | 23.10% | 20.34% | 14.63% | 22.51% | Upgrade
|
| Profit Margin | 3.69% | 7.83% | 18.59% | 15.57% | 12.96% | 19.76% | Upgrade
|
| Free Cash Flow Margin | 11.85% | 10.53% | 10.21% | 22.90% | 17.13% | 12.89% | Upgrade
|
| EBITDA | 652 | 418.24 | 304.5 | 264.73 | 178.35 | 229.49 | Upgrade
|
| EBITDA Margin | 26.31% | 26.67% | 29.77% | 27.63% | 22.60% | 29.22% | Upgrade
|
| D&A For EBITDA | 256.96 | 144.73 | 68.25 | 69.87 | 62.87 | 52.73 | Upgrade
|
| EBIT | 395.04 | 273.51 | 236.25 | 194.86 | 115.47 | 176.75 | Upgrade
|
| EBIT Margin | 15.94% | 17.44% | 23.10% | 20.34% | 14.63% | 22.51% | Upgrade
|
| Effective Tax Rate | 24.40% | 25.71% | 21.75% | 17.30% | 18.76% | 18.29% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.